{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20251117",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "84192",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761347s005lbl.pdf",
              "date": "20251118",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20251002",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "83651",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761347s003lbl.pdf",
              "date": "20251003",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20260515",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20251124",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "84300",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761347s004lbl.pdf",
              "date": "20251125",
              "type": "Label"
            },
            {
              "id": "84301",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761347s004lbl.pdf#page=79",
              "date": "20251125",
              "type": "Medication Guide"
            },
            {
              "id": "84306",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761347Orig1s004ltr.pdf",
              "date": "20251125",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20240912",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "79595",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761347s000lbl.pdf",
              "date": "20240916",
              "type": "Label"
            },
            {
              "id": "79623",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761347Orig1s000ltr.pdf",
              "date": "20240916",
              "type": "Letter"
            },
            {
              "id": "81921",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/761347Orig1s000TOC.html",
              "date": "20250410",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20250818",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83140",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761347Orig1s002ltr.pdf",
              "date": "20250819",
              "type": "Letter"
            },
            {
              "id": "83142",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761347s002lbl.pdf",
              "date": "20250820",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20260512",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "85908",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761347Orig1s009ltr.pdf",
              "date": "20260513",
              "type": "Letter"
            },
            {
              "id": "85947",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761347s009lbl.pdf",
              "date": "20260518",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761347",
      "sponsor_name": "GENENTECH INC",
      "openfda": {
        "application_number": [
          "BLA761347"
        ],
        "brand_name": [
          "TECENTRIQ HYBREZA"
        ],
        "generic_name": [
          "ATEZOLIZUMAB AND HYALURONIDASE-TQJS"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-933"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "ATEZOLIZUMAB",
          "HYALURONIDASE (HUMAN RECOMBINANT)"
        ],
        "rxcui": [
          "2693892",
          "2693899"
        ],
        "spl_id": [
          "9bc7ee05-8ccb-489b-94a9-eb317f72324e"
        ],
        "spl_set_id": [
          "a617b089-ce66-464b-987b-b45d029b4d6f"
        ],
        "package_ndc": [
          "50242-933-01",
          "50242-933-86"
        ],
        "nui": [
          "N0000191260",
          "N0000191259",
          "M0556300",
          "M0001357",
          "M0001352",
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "Programmed Death Receptor-1 Blocking Antibody [EPC]",
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_moa": [
          "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"
        ],
        "pharm_class_cs": [
          "Antibodies, Monoclonal, Humanized [CS]",
          "Antibodies, Monoclonal [CS]",
          "Antibodies [CS]",
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "52CMI0WC3Y",
          "743QUY4VD8"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "TECENTRIQ HYBREZA",
          "active_ingredients": [
            {
              "name": "ATEZOLIZUMAB AND HYALURONIDASE-TQJS",
              "strength": "125MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}